Neuphoria Therapeutics Inc. (NEUP) NASDAQ

6.24

+2.19(+54.07%)

Updated at October 24 04:00PM

Currency In USD

Valuation

Market Cap11.52B
Enterprise Value-2.57B
P/E Ratio250.61
PEG Ratio11.15
Price/Sales Ratio0.75
Price/Book Ratio56.17
Enterprise/Revenue-0.33
Enterprise/EBITDA-2.53

Fiscal Year

Fiscal YearJune 30, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.37
Operating Margin-0.05

Management Effectiveness

Return On Assets0.19
Return On Equity0.31

Income Statement

Revenue0
Revenue/Share0.07
Gross Profit0
EBITDA-1.13B
Net Income-369.63M
Diluted EPS-0.23

Balance Sheet

Total Cash17.05M
Total Cash/Share0.07
Total Debt172,460
Total Debt/Equity0.01
Current Ratio11.01
Book Value Per Share0.11

Price History

52-Week Change110.81
52-Week High21.4
52-Week Low2.12
Moving Average 50 Days12.09
Moving Average 200 Days7.39

Statistics

Average Volume1.44M
Shares Outstanding1.88M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateDecember 24, 2024